9th Nov 2007 15:24
Allergy Therapeutics PLC09 November 2007 TR-1: notification of major interests in shares 1. Identity of the issuer or the underlying issuer of existing Allergy Therapeutics plcshares to which voting rights are attached:2. Reason for the notification (please tick the appropriate box or boxes):An acquisition or disposal of voting rightsAn acquisition or disposal of financial instruments which may result in the acquisition ofshares already issued to which voting rights are attachedAn event changing the breakdown of voting rightsOther: Transferred to external fund manager X3. Full name of person(s) subject to the notification obligation: BT Pension Scheme Trustees Limited as trustess of the BT Pension Scheme4. Full name of shareholder(s) (if different from 3.): N/A5. Date of the transaction and date on which the threshold is 1 November 2007crossed or reached:6. Date on which issuer notified: 8 November 20077. Threshold that is reached or crossed: 3% 8. Notified details: A: Voting rights attached to sharesClass/type of shares Situation previous Resulting situation after the triggering transaction to the Triggeringif possible using the transactionISIN CODE Number of Number of Number of Number of voting rights % of voting rights Shares Voting shares Rights Direct Direct Indirect Direct IndirectGB00B02LCQ05 4,540,027 2,511,761 2,511,761 0 3.06% 0.00% ORD £0.001 B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ convertedN/A N/A N/A N/A N/A Total (A+B)Number of voting rights % of voting rights2,511,761 3.06% 9 Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable: Proxy Voting:10 Name of the proxy holder: See 13 below11 Number of voting rights proxy holder will cease to hold: See 13 below12 Date on which proxy holder will cease to hold voting rights: See 13 below 13 Additional information: Hermes Investment Management Limited hold the voting rights under a standing proxy contained in investment management agreements with various underlying clients, which includes all of the shares owned directly by the BT Pension Scheme. All voting rights held on behalf of the above entities are aggregated for the purposes of DTR 5.2.1(a) and disclosed pursuant to DTR 5.1.5. This disclosure is made by BT Pension Shceme Trustees Limited, which is the ultimate parent undertaking for the purposes of DTR 5.2.1(e). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.